Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Brain Neoplasms × Memantine × 30 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 1

Interventions

Radiosurgery 12 Magnetic Resonance Spectroscopy 8 Temozolomide 7 Bevacizumab 6 Specimen Handling 5 trastuzumab deruxtecan 4 pembrolizumab 4 Radiotherapy 4 Nivolumab 4 Cyclophosphamide 4 Biopsy 4 abemaciclib 3 Ipilimumab 3 entrectinib 2 cabozantinib 2 Trastuzumab 2 Surveys and Questionnaires 2 Surgical Procedures, Operative 2 Sirolimus 2 Receptors, Interleukin-8B 2 Mental Status and Dementia Tests 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 Dexamethasone 2 Adrenal Cortex Hormones 2 trastuzumab biosimilar HLX02 1 temsirolimus 1 ribociclib 1 repotrectinib 1 regorafenib 1 pertuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07470606 2026-03-13

MemoryRT

The University of Texas Health Science Center at San Antonio

Phase 2 Not yet recruiting

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡